← All trials
NCT00192660
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2003
- Primary completion
- Oct 1, 2006
- Completion date
- Dec 1, 2007
- First posted
- —
- Last posted
- —
- Enrollment
- 80
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- University of New South WalesLead sponsor
- The National Centre in HIV Epidemiology and Clinical Research, SydneyStudy director
- National Heart, Lung, and Blood Institute (NHLBI)Collaborator
- University of New South WalesCollaborator
- University of New South WalesOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.